Achieving Precision Healthcare through Nanomedicine and Enhanced Model Systems
ACS Materials Au · 13.03.2024 · 4 (2) · 162-173
DOI: 10.1021/acsmaterialsau.3c00073 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Materials Au, online erschienen am 18.12.2023. Verfasst von Elin Svensson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemical Biology, Department of Life Sciences, Chalmers University of Technology, Gothenburg 412 96, Sweden. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftelsen Sigurd and Elsa Goljes Minne, Vetenskapsr?det, Stiftelsen Konung Gustaf V:s 80-?rsfond.
Abstract (Originalsprache)
The ability to customize medical choices according to an individual's genetic makeup and biomarker patterns marks a significant advancement toward overall improved healthcare for both individuals and society at large. By transitioning from the conventional one-size-fits-all approach to tailored treatments that can account for predispositions of different patient populations, nanomedicines can be customized to target the specific molecular underpinnings of a patient's disease, thus mitigating the risk of collateral damage. However, for these systems to reach their full potential, our understanding of how nano-based therapeutics behave within the intricate human body is necessary. Effective drug administration to the targeted organ or pathological niche is dictated by properties such as nanocarrier (NC) size, shape, and targeting abilities, where understanding how NCs change their properties when they encounter biomolecules and phenomena such as shear stress in flow remains a major challenge. This Review specifically focuses on vessel-on-a-chip technology that can provide increased understanding of NC behavior in blood and summarizes the specialized environment of the joint to showcase advanced tissue models as approaches to address translational challenges. Compared to conventional cell studies or animal models, these advanced models can integrate patient material for full customization. Combining such models with nanomedicine can contribute to making personalized medicine achievable.
Autor:innen und Institutionen
- Division of Chemical Biology, Department of Life Sciences, Chalmers University of Technology, Gothenburg 412 96, Sweden.
ORCID-Profile: Alexandra Stubelius
Förderung
- Stiftelsen Sigurd and Elsa Goljes Minne
- Vetenskapsr?det
- Stiftelsen Konung Gustaf V:s 80-?rsfond
- Stiftelserna Wilhelm och Martina Lundgrens
- Stiftelsen Chalmers tekniska h?gskola
- IngaBritt och Arne Lundbergs Forskningsstiftelse
- Royal Swedish Academy of Sciences
- Reumatikerf?rbundet
Zitieren
APA
Svensson, E., von Mentzer, U., & Stubelius, A. (2024). Achieving Precision Healthcare through Nanomedicine and Enhanced Model Systems. ACS Materials Au, 4(2), 162-173. https://doi.org/10.1021/acsmaterialsau.3c00073
Vancouver
Svensson E, von Mentzer U, Stubelius A. Achieving Precision Healthcare through Nanomedicine and Enhanced Model Systems. ACS Materials Au. 2024;4(2):162-173. doi:10.1021/acsmaterialsau.3c00073
BibTeX
@article{Svensson2024,
author = {Svensson, Elin and von Mentzer, Ula and Stubelius, Alexandra},
title = {Achieving Precision Healthcare through Nanomedicine and Enhanced Model Systems},
journal = {ACS Materials Au},
year = {2024},
volume = {4},
number = {2},
pages = {162--173},
doi = {10.1021/acsmaterialsau.3c00073}
}
EUVIMED